NCT04500912 - Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population | Biotech Hunter

Enrollment

736

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions

Cardiac DiseasePCIHigh Bleeding Risk

Interventions

DEVICE

Supraflex Cruz 60 Micron

percutaneous coronary intervention

DEVICE

Ultimaster Tansei 80 Micron

percutaneous coronary intervention

Trial Locations (11)

Jeroen Bosch ziekenhuis, 's-Hertogenbosch

Meander ziekenhuis, Amersfoort

Rijnstate ziekenhuis, Arnhem

Tergooi ziekenhuis Blaricum, Blaricum

Amphia Ziekenhuis, Breda

Albert Schweitzer ziekenhuis, Dordrecht

Catherina ziekenhuis, Eindhoven

MCL Leeuwarden, Leeuwarden

St.Antonius ziekenhuis, Nieuwegein

Maasstadziekenhuis, Rotterdam

Ziekenhuis Zorgsaam, Terneuzen

All Listed Sponsors

collaborator

Sahajanand Medical Technologies Limited

INDUSTRY

lead

Pieter C.Smits

OTHER